Cargando…
Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
BACKGROUND: The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads rapidly and insidiously. Coronavirus disease 2019 (COVID-19) screening is an important means of blocking community transmission in China, but the costs associated with testing are high. Quarantine...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841147/ https://www.ncbi.nlm.nih.gov/pubmed/36642738 http://dx.doi.org/10.1186/s40249-022-01049-w |
_version_ | 1784869769090957312 |
---|---|
author | Yin, Yun Liu, Yuanhua Duan, Mengwei Xie, Xiyang Hong, Jie Huang, Jiaqi Li, Ke Shi, Jin Chen, Xi Guo, Hongyan Zhou, Xuan Liu, Rui Zhou, Caifeng Wang, Xiaozhe Kong, Lingcai Zhang, Zhijie |
author_facet | Yin, Yun Liu, Yuanhua Duan, Mengwei Xie, Xiyang Hong, Jie Huang, Jiaqi Li, Ke Shi, Jin Chen, Xi Guo, Hongyan Zhou, Xuan Liu, Rui Zhou, Caifeng Wang, Xiaozhe Kong, Lingcai Zhang, Zhijie |
author_sort | Yin, Yun |
collection | PubMed |
description | BACKGROUND: The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads rapidly and insidiously. Coronavirus disease 2019 (COVID-19) screening is an important means of blocking community transmission in China, but the costs associated with testing are high. Quarantine capacity and medical resources are also threatened. Therefore, we aimed to evaluate different screening strategies to balance outbreak control and consumption of resources. METHODS: A community network of 2000 people, considering the heterogeneities of household size and age structure, was generated to reflect real contact networks, and a stochastic individual-based dynamic model was used to simulate SARS-CoV-2 transmission and assess different whole-area nucleic acid screening strategies. We designed a total of 87 screening strategies with different sampling methods, frequencies of screening, and timings of screening. The performance of these strategies was comprehensively evaluated by comparing the cumulative infection rates, the number of tests, and the quarantine capacity and consumption of medical resource, which were expressed as medians (95% uncertainty intervals, 95% UIs). RESULTS: To implement COVID-19 nucleic acid testing for all people (Full Screening), if the screening frequency was four times/week, the cumulative infection rate could be reduced to 13% (95% UI: 1%, 51%), the miss rate decreased to 2% (95% UI: 0%, 22%), and the quarantine and medical resource consumption was lower than higher-frequency Full Screening or sampling screening. When the frequency of Full Screening increased from five to seven times/week (which resulted in a 2581 increase in the number of tests per positive case), the cumulative infection rate was only reduced by 2%. Screening all people weekly by splitting them equally into seven batches could reduce infection rates by 73% compared to once per week, which was similar to Full Screening four times/week. Full Screening had the highest number of tests per positive case, while the miss rate, number of tests per positive case, and hotel quarantine resource consumption in Household-based Sampling Screening scenarios were lower than Random Sampling Screening. The cumulative infection rate of Household-based Sampling Screening or Random Sampling Screening seven times/week was similar to that of Full Screening four times/week. CONCLUSIONS: If hotel quarantine, hospital and shelter hospital capacity are seriously insufficient, to stop the spread of the virus as early as possible, high-frequency Full Screening would be necessary, but intermediate testing frequency may be more cost-effective in non-extreme situations. Screening in batches is recommended if the testing capacity is low. Household-based Sampling Screening is potentially a promising strategy to implement. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-022-01049-w. |
format | Online Article Text |
id | pubmed-9841147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98411472023-01-17 Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study Yin, Yun Liu, Yuanhua Duan, Mengwei Xie, Xiyang Hong, Jie Huang, Jiaqi Li, Ke Shi, Jin Chen, Xi Guo, Hongyan Zhou, Xuan Liu, Rui Zhou, Caifeng Wang, Xiaozhe Kong, Lingcai Zhang, Zhijie Infect Dis Poverty Research Article BACKGROUND: The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads rapidly and insidiously. Coronavirus disease 2019 (COVID-19) screening is an important means of blocking community transmission in China, but the costs associated with testing are high. Quarantine capacity and medical resources are also threatened. Therefore, we aimed to evaluate different screening strategies to balance outbreak control and consumption of resources. METHODS: A community network of 2000 people, considering the heterogeneities of household size and age structure, was generated to reflect real contact networks, and a stochastic individual-based dynamic model was used to simulate SARS-CoV-2 transmission and assess different whole-area nucleic acid screening strategies. We designed a total of 87 screening strategies with different sampling methods, frequencies of screening, and timings of screening. The performance of these strategies was comprehensively evaluated by comparing the cumulative infection rates, the number of tests, and the quarantine capacity and consumption of medical resource, which were expressed as medians (95% uncertainty intervals, 95% UIs). RESULTS: To implement COVID-19 nucleic acid testing for all people (Full Screening), if the screening frequency was four times/week, the cumulative infection rate could be reduced to 13% (95% UI: 1%, 51%), the miss rate decreased to 2% (95% UI: 0%, 22%), and the quarantine and medical resource consumption was lower than higher-frequency Full Screening or sampling screening. When the frequency of Full Screening increased from five to seven times/week (which resulted in a 2581 increase in the number of tests per positive case), the cumulative infection rate was only reduced by 2%. Screening all people weekly by splitting them equally into seven batches could reduce infection rates by 73% compared to once per week, which was similar to Full Screening four times/week. Full Screening had the highest number of tests per positive case, while the miss rate, number of tests per positive case, and hotel quarantine resource consumption in Household-based Sampling Screening scenarios were lower than Random Sampling Screening. The cumulative infection rate of Household-based Sampling Screening or Random Sampling Screening seven times/week was similar to that of Full Screening four times/week. CONCLUSIONS: If hotel quarantine, hospital and shelter hospital capacity are seriously insufficient, to stop the spread of the virus as early as possible, high-frequency Full Screening would be necessary, but intermediate testing frequency may be more cost-effective in non-extreme situations. Screening in batches is recommended if the testing capacity is low. Household-based Sampling Screening is potentially a promising strategy to implement. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-022-01049-w. BioMed Central 2023-01-16 /pmc/articles/PMC9841147/ /pubmed/36642738 http://dx.doi.org/10.1186/s40249-022-01049-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Yin, Yun Liu, Yuanhua Duan, Mengwei Xie, Xiyang Hong, Jie Huang, Jiaqi Li, Ke Shi, Jin Chen, Xi Guo, Hongyan Zhou, Xuan Liu, Rui Zhou, Caifeng Wang, Xiaozhe Kong, Lingcai Zhang, Zhijie Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study |
title | Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study |
title_full | Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study |
title_fullStr | Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study |
title_full_unstemmed | Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study |
title_short | Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study |
title_sort | optimizing the nucleic acid screening strategy to mitigate regional outbreaks of sars-cov-2 omicron variant in china: a modeling study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841147/ https://www.ncbi.nlm.nih.gov/pubmed/36642738 http://dx.doi.org/10.1186/s40249-022-01049-w |
work_keys_str_mv | AT yinyun optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT liuyuanhua optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT duanmengwei optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT xiexiyang optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT hongjie optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT huangjiaqi optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT like optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT shijin optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT chenxi optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT guohongyan optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT zhouxuan optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT liurui optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT zhoucaifeng optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT wangxiaozhe optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT konglingcai optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy AT zhangzhijie optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy |